Jan Szollos is a TechBio Business Strategist.
Last updated
Jan Szollos is a business development and strategy professional specializing in healthcare and life sciences, with a focus on AI-driven drug discovery and biomarker development. He collaborates with expert teams to make machine learning solutions more accessible in the pharmaceutical and biotech industries. Jan frequently shares insights on AI applications in drug R&D, participates in industry conferences, and engages with the TechBio community. His content highlights his roles at companies like QurieGen and Insilico Medicine, emphasizing cutting-edge technology and scientific advancements.
AI-powered virtual cell models will be the crucial next step in drug R&D.
Favikon helps you find the right creators, analyze them in depth, reach out at scale, and track what works.